Biofidelity: Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials
New partnership to advance precision medicine in lung cancer diagnosis
Read full article »
Biofidelity is an England-based genomic technology company that develops and markets biomarkers and reagents for physicians, biopharma companies and lab directors.
Read more